Global and Europe Antitumor Drugs of Antibiotics Market - Analysis and Outlook to 2022

Published: Aug, 2017 | Pages: 111 | Publisher: EU Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

This report presents a comprehensive overview of the Antitumor Drugs of Antibiotics market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Antitumor Drugs of Antibiotics industry.

This report focuses Global and Europe market,  including details as following:

Key Players
    BASF SE DE 67056 Ludwigshafen
    BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul
    INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad
    MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo
    MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo
    NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo
    OLON S.P.A. IT 20090 Rodano
    SICOR S.R.L. IT 20017 Rho
    TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva
    Transo-Pharm Handels GmbH DE 22962 Siek

Key Regions
    North America
        United States
        Canada
    Latin America
        Mexico
        Brazil
        Argentina
        Others
    Europe
        Germany
        United Kingdom
        France
        Italy
        Spain
        Russia
        Netherland
        Others
    Asia & Pacific
        China
        Japan
        India
        Korea
        Australia
        Southeast Asia
            Indonesia
            Thailand
            Philippines
            Vietnam
            Singapore
            Malaysia
            Others
    Africa & Middle East
        South Africa
        Egypt
        Turkey
        Saudi Arabia
        Iran
        Others

Key Product Type
Antitumor Drugs of Antibiotics Market, by Antibiotic Class
    Doxorubicin
    Zorubicin
    Valrubicin
    Mitomycin C
    Bleomycin
    Idarubicin
    Daunorubicin
    Mithramycin
    Bruneomycin
    Aclarubicin
    Bleomycin
    Aclarubicin

Key Applications
    Oncology Department
    Department of Chemotherapy
    Pharmacology

 Table of Contents

Global and Europe Antitumor Drugs of Antibiotics Market - Analysis and Outlook to 2022
1 Market Outline
    1.1 Research Methodology
        1.1.1 Methodology/Research Approach
            Research Programs/Design
            Market Size Estimation
            Market Breakdown and Data Triangulation
        1.1.2 Data Source
            Secondary Sources
            Primary Sources
        1.1.3 Disclaimer
    1.2 Regulatory Factors
    1.3 End-User Analysis
    1.4 Strategic Benchmarking
    1.5 Industry Chain and Supply Chain
        1.5.1 Antitumor Drugs of Antibiotics Industry Chain Structure
            1.5.1.1 R&D
            1.5.1.2 Raw Materials (Components)
            1.5.1.3 Manufacturing Plants
            1.5.1.4 Regional Trading (Import Export and Local Sales)
            1.5.1.5 Online Sales Channel
            1.5.1.6 Offline Channel
            1.5.1.7 End Users
        1.5.2 Antitumor Drugs of Antibiotics Manufacturing
            1.5.2.1 Key Components
            1.5.2.2 Assembly Manufacturing
        1.5.3 Consumer Preference
        1.5.4 Behavioral Habits
        1.5.5 Marketing Environment
    1.6 SWOT Analysis
    1.7 Feasibility Analysis
    1.8 Development Trend and Research Conclusion
        1.8.1 Development Trend
        1.8.2 Research Conclusion

2 Global Antitumor Drugs of Antibiotics Product Overview
    2.1 Global Antitumor Drugs of Antibiotics Market Sales Volume Revenue and Price 2012-2017
    2.2 Antitumor Drugs of Antibiotics, by Antibiotic Class 2012-2017
        2.2.1 Global Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class 2012-2017
        2.2.2 Global Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class 2012-2017
        2.2.3 Global Antitumor Drugs of Antibiotics Price by Antibiotic Class 2012-2017
        2.2.4 Doxorubicin
        2.2.5 Zorubicin
        2.2.6 Valrubicin
        2.2.7 Mitomycin C
        2.2.8 Bleomycin
              Daunorubicin
              Mithramycin
              Bruneomycin
              Aclarubicin
              Bleomycin
              Aclarubicin

3 Europe Antitumor Drugs of Antibiotics Product Overview
    3.1 Europe Antitumor Drugs of Antibiotics Market Sales Volume Revenue and Price 2012-2017
    3.2 Antitumor Drugs of Antibiotics, by Antibiotic Class 2012-2017
        3.2.1 Europe Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class 2012-2017
        3.2.2 Europe Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class 2012-2017
        3.2.3 Europe Antitumor Drugs of Antibiotics Price by Antibiotic Class 2012-2017
        3.2.4 Doxorubicin
        3.2.5 Zorubicin
        3.2.6 Valrubicin
        3.2.7 Mitomycin C
        3.2.8 Bleomycin
              Daunorubicin
              Mithramycin
              Bruneomycin
              Aclarubicin
              Bleomycin
              Aclarubicin

4 Antitumor Drugs of Antibiotics Top Companies Profile
    4.1 BASF SE DE 67056 Ludwigshafen
        4.1.1 BASF SE DE 67056 Ludwigshafen Company Details and Competitors
        4.1.2 BASF SE DE 67056 Ludwigshafen Key Antitumor Drugs of Antibiotics Models and Performance
        4.1.3 BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.1.4 BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.2 BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul
        4.2.1 BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Company Details and Competitors
        4.2.2 BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Key Antitumor Drugs of Antibiotics Models and Performance
        4.2.3 BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.2.4 BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.3 INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad
        4.3.1 INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Company Details and Competitors
        4.3.2 INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Key Antitumor Drugs of Antibiotics Models and Performance
        4.3.3 INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.3.4 INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.4 MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo
        4.4.1 MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Company Details and Competitors
        4.4.2 MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
        4.4.3 MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.4.4 MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.5 MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo
        4.5.1 MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Company Details and Competitors
        4.5.2 MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
        4.5.3 MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.5.4 MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.6 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo
        4.6.1 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Company Details and Competitors
        4.6.2 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
        4.6.3 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.6.4 NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.7 OLON S.P.A. IT 20090 Rodano
        4.7.1 OLON S.P.A. IT 20090 Rodano Company Details and Competitors
        4.7.2 OLON S.P.A. IT 20090 Rodano Key Antitumor Drugs of Antibiotics Models and Performance
        4.7.3 OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.7.4 OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.8 SICOR S.R.L. IT 20017 Rho
        4.8.1 SICOR S.R.L. IT 20017 Rho Company Details and Competitors
        4.8.2 SICOR S.R.L. IT 20017 Rho Key Antitumor Drugs of Antibiotics Models and Performance
        4.8.3 SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.8.4 SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.9 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva
        4.9.1 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Company Details and Competitors
        4.9.2 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Key Antitumor Drugs of Antibiotics Models and Performance
        4.9.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.9.4 TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin
    4.10 Transo-Pharm Handels GmbH DE 22962 Siek
        4.10.1 Transo-Pharm Handels GmbH DE 22962 Siek Company Details and Competitors
        4.10.2 Transo-Pharm Handels GmbH DE 22962 Siek Key Antitumor Drugs of Antibiotics Models and Performance
        4.10.3 Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
        4.10.4 Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Sales Volume Revenue Price Cost and Gross Margin

5 Antitumor Drugs of Antibiotics by Regions 2012-2017
    5.1 Global Antitumor Drugs of Antibiotics Sales Market Share by Regions 2012-2017
    5.2 Global Antitumor Drugs of Antibiotics Revenue Market Share by Regions 2012-2017
    5.3 Global Antitumor Drugs of Antibiotics Price by Regions 2012-2017
    5.4 North America
        5.4.1 United States
        5.4.2 Canada
    5.5 Latin America
        5.5.1 Mexico
        5.5.2 Brazil
        5.5.3 Argentina
        5.5.4 Others in Latin America
    5.6 Europe
        5.6.1 Germany
        5.6.2 United Kingdom
        5.6.3 France
        5.6.4 Italy
        5.6.5 Spain
        5.6.6 Russia
        5.6.7 Netherland
        5.6.8 Others in Europe
    5.7 Asia & Pacific
        5.7.1 China
        5.7.2 Japan
        5.7.3 India
        5.7.4 Korea
        5.7.5 Australia
        5.7.6 Southeast Asia
            5.7.6.1 Indonesia
            5.7.6.2 Thailand
            5.7.6.3 Philippines
            5.7.6.4 Vietnam
            5.7.6.5 Singapore
            5.7.6.6 Malaysia
            5.7.6.7 Others in Southeast Asia
    5.8 Africa & Middle East
        5.8.1 South Africa
        5.8.2 Egypt
        5.8.3 Turkey
        5.8.4 Saudi Arabia
        5.8.5 Iran
        5.8.6 Others in Africa & Middle East

6 GlobalAntitumor Drugs of Antibiotics by Players 2012-2017
    6.1 Global Antitumor Drugs of Antibiotics Sales Volume Market Share by Brands 2012-2017
    6.2 Global Antitumor Drugs of Antibiotics Revenue Share by Brands 2012-2017
    6.3 Global Top Players Antitumor Drugs of Antibiotics Key Product Model and Market Performance
    6.4 Global Top Players Antitumor Drugs of Antibiotics Key Target Consumers and Market Performance

7 EuropeAntitumor Drugs of Antibiotics by Players 2012-2017
    7.1 Europe Antitumor Drugs of Antibiotics Sales Volume Market Share by Brands 2012-2017
    7.2 Europe Antitumor Drugs of Antibiotics Revenue Share by Brands 2012-2017
    7.3 Europe Top Players Antitumor Drugs of Antibiotics Key Product Model and Market Performance
    7.4 Europe Top Players Antitumor Drugs of Antibiotics Key Target Consumers and Market Performance

8 Global Antitumor Drugs of Antibiotics by Consumer 2012-2017
    8.1 Global Antitumor Drugs of Antibiotics Sales Market Share by Consumer 2012-2017
    8.2 Oncology Department
    8.3 Department of Chemotherapy
    8.4 Pharmacology
    8.5 Consuming Habit and Preference

9 Europe Antitumor Drugs of Antibiotics by Consumer 2012-2017
    9.1 Europe Antitumor Drugs of Antibiotics Sales Market Share by Consumer 2012-2017
    9.2 Oncology Department
    9.3 Department of Chemotherapy
    9.4 Pharmacology
    9.5 Consuming Habit and Preference

10 Global Antitumor Drugs of Antibiotics Market Size (Sales and Revenue) Forecast (2017-2022)
    10.1 Global Antitumor Drugs of Antibiotics Sales (), Revenue (Million USD) Forecast (2017-2022)
    10.2 Global Antitumor Drugs of Antibiotics Sales () Forecast by Regions (2017-2022)
    10.3 Global Antitumor Drugs of Antibiotics Sales () Forecast by Application (2017-2022)
    10.4 Global Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    10.5 Global Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)

11 Europe Antitumor Drugs of Antibiotics Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 Europe Antitumor Drugs of Antibiotics Sales (), Revenue (Million USD) Forecast (2017-2022)
    11.2 Europe Antitumor Drugs of Antibiotics Sales () Forecast by Regions (2017-2022)
    11.3 Europe Antitumor Drugs of Antibiotics Sales () Forecast by Application (2017-2022)
    11.4 Europe Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    11.5 Europe Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)

List of Tables and Figures

    Table Global Antitumor Drugs of Antibiotics Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales () by Antibiotic Class (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class in 2016
    Table Global Antitumor Drugs of Antibiotics Revenue (Million USD) by Antibiotic Class (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class in 2016
    Table Global Antitumor Drugs of Antibiotics Price () by Antibiotic Class (2012-2017)
    Table Top Players of Doxorubicin Antitumor Drugs of Antibiotics Products List
    Figure Global Doxorubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Zorubicin Antitumor Drugs of Antibiotics Products List
    Figure Global Zorubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Valrubicin Antitumor Drugs of Antibiotics Products List
    Figure Global Valrubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Mitomycin C Antitumor Drugs of Antibiotics Products List
    Figure Global Mitomycin C Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Bleomycin Antitumor Drugs of Antibiotics Products List
    Figure Global Bleomycin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales () by  (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by  in 2016
    Table Global Antitumor Drugs of Antibiotics Revenue (Million USD) by  (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Revenue Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by  in 2016
    Table Global Antitumor Drugs of Antibiotics Price () by  (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales () by  (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by  in 2016
    Table Global Antitumor Drugs of Antibiotics Revenue (Million USD) by  (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Revenue Market Share by  (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by  in 2016
    Table Global Antitumor Drugs of Antibiotics Price () by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales () by Antibiotic Class (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Market Share by Antibiotic Class in 2016
    Table Europe Antitumor Drugs of Antibiotics Revenue (Million USD) by Antibiotic Class (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Revenue Market Share by Antibiotic Class in 2016
    Table Europe Antitumor Drugs of Antibiotics Price () by Antibiotic Class (2012-2017)
    Table Top Players of Doxorubicin Antitumor Drugs of Antibiotics Products List
    Figure Europe Doxorubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Zorubicin Antitumor Drugs of Antibiotics Products List
    Figure Europe Zorubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Valrubicin Antitumor Drugs of Antibiotics Products List
    Figure Europe Valrubicin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Mitomycin C Antitumor Drugs of Antibiotics Products List
    Figure Europe Mitomycin C Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Top Players of Bleomycin Antitumor Drugs of Antibiotics Products List
    Figure Europe Bleomycin Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales () by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Market Share by  in 2016
    Table Europe Antitumor Drugs of Antibiotics Revenue (Million USD) by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Revenue Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Revenue Market Share by  in 2016
    Table Europe Antitumor Drugs of Antibiotics Price () by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales () by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Market Share by  in 2016
    Table Europe Antitumor Drugs of Antibiotics Revenue (Million USD) by  (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Revenue Market Share by  (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Revenue Market Share by  in 2016
    Table Europe Antitumor Drugs of Antibiotics Price () by  (2012-2017)
    Table BASF SE DE 67056 Ludwigshafen Company Details and Competitors
    Table BASF SE DE 67056 Ludwigshafen Key Antitumor Drugs of Antibiotics Models and Performance
    Table BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BASF SE DE 67056 Ludwigshafen Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Company Details and Competitors
    Table BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Key Antitumor Drugs of Antibiotics Models and Performance
    Table BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure BORYUNG PHARMACEUTICAL CO., LTD. KR 110-750 Seoul Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Company Details and Competitors
    Table INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Key Antitumor Drugs of Antibiotics Models and Performance
    Table INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure INTAS PHARMACEUTICALS LIMITED IN 380 009 Ahmedabad Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Company Details and Competitors
    Table MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
    Table MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure MEIJI SEIKA PHARMA CO., LTD. JP 104-8002 Tokyo Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Company Details and Competitors
    Table MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
    Table MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure MICROBIOPHARM JAPAN CO., LTD. JP 104-0031 Tokyo Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Company Details and Competitors
    Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Key Antitumor Drugs of Antibiotics Models and Performance
    Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure NIPPON KAYAKU CO., LTD. JP 100-0005 Tokyo Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table OLON S.P.A. IT 20090 Rodano Company Details and Competitors
    Table OLON S.P.A. IT 20090 Rodano Key Antitumor Drugs of Antibiotics Models and Performance
    Table OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure OLON S.P.A. IT 20090 Rodano Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table SICOR S.R.L. IT 20017 Rho Company Details and Competitors
    Table SICOR S.R.L. IT 20017 Rho Key Antitumor Drugs of Antibiotics Models and Performance
    Table SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure SICOR S.R.L. IT 20017 Rho Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Company Details and Competitors
    Table TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Key Antitumor Drugs of Antibiotics Models and Performance
    Table TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure TEVA PHARMACEUTICAL INDUSTRIES LTD. IL 4951033 Petach Tikva Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table Transo-Pharm Handels GmbH DE 22962 Siek Company Details and Competitors
    Table Transo-Pharm Handels GmbH DE 22962 Siek Key Antitumor Drugs of Antibiotics Models and Performance
    Table Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Business SWOT Analysis and Forecast
    Table Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
    Figure Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Sales(Million Unit) and Growth Rate (%)(2012-2017)
    Figure Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Sales Market Share (%) in Global (2012-2017)
    Figure Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)
    Figure Transo-Pharm Handels GmbH DE 22962 Siek Antitumor Drugs of Antibiotics Revenue Market Share (%) in Global (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales Share by Regions (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by Regions in 2016
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by Regions in 2017
    Table Global Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Revenue Market Share by Regions (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by Regions in 2016
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by Regions in 2017
    Table Global Antitumor Drugs of Antibiotics Price () by Regions (2012-2017)
    Table North America Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table North America Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Figure North America Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Latin America Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table Latin America Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Figure Latin America Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Asia & Pacific Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table Asia & Pacific Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Figure Asia & Pacific Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Africa & Middle East Antitumor Drugs of Antibiotics Sales () by Regions (2012-2017)
    Table Africa & Middle East Antitumor Drugs of Antibiotics Revenue (Million USD) by Regions (2012-2017)
    Figure Africa & Middle East Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Global Antitumor Drugs of Antibiotics Sales Volume () by Key Players 2012-2017
    Table Global Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2012-2017
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2016
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2017
    Table Global Antitumor Drugs of Antibiotics Revenue (Million USD) by Key Players 2012-2017
    Table Global Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2012-2017
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2016
    Figure Global Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2017
    Table Global Top Players Key Product Model and Market Performance
    Table Global Top Players Key Target Consumers and Market Performance
    Table Europe Antitumor Drugs of Antibiotics Sales Volume () by Key Players 2012-2017
    Table Europe Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2012-2017
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2016
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share by Key Players 2017
    Table Europe Antitumor Drugs of Antibiotics Revenue (Million USD) by Key Players 2012-2017
    Table Europe Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2012-2017
    Figure Europe Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2016
    Figure Europe Antitumor Drugs of Antibiotics Revenue Market Share by Key Players 2017
    Table Europe Top Players Key Product Model and Market Performance
    Table Europe Top Players Key Target Consumers and Market Performance
    Table Global Antitumor Drugs of Antibiotics Sales () by Consumer (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by Consumer (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales Market Share by Consumer in 2016
    Figure Global Oncology Department Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Figure Global Department of Chemotherapy Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Figure Global Pharmacology Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Table Europe Antitumor Drugs of Antibiotics Sales () by Consumer (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Market Share by Consumer (2012-2017)
    Figure Europe Antitumor Drugs of Antibiotics Sales Market Share by Consumer in 2016
    Figure Europe Oncology Department Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Figure Europe Department of Chemotherapy Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Figure Europe Pharmacology Antitumor Drugs of Antibiotics Sales () and Growth Rate (2012-2017)
    Figure Global Antitumor Drugs of Antibiotics Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Price () Trend Forecast (2017-2022)
    Table Global Antitumor Drugs of Antibiotics Sales () Forecast by Regions (2017-2022)
    Table Global Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions in 2022
    Table Global Antitumor Drugs of Antibiotics Sales () Forecast by Application (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Application in 2022
    Table Global Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Antibiotic Class in 2022
    Table Global Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)
    Figure Global Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by  in 2022
    Figure Europe Antitumor Drugs of Antibiotics Sales () and Growth Rate (%) Forecast (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Price () Trend Forecast (2017-2022)
    Table Europe Antitumor Drugs of Antibiotics Sales () Forecast by Regions (2017-2022)
    Table Europe Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Share Forecast by Regions in 2022
    Table Europe Antitumor Drugs of Antibiotics Sales () Forecast by Application (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Application in 2022
    Table Europe Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales () Forecast by Antibiotic Class (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by Antibiotic Class in 2022
    Table Europe Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales () Forecast by  (2017-2022)
    Figure Europe Antitumor Drugs of Antibiotics Sales Volume Market Share Forecast by  in 2022